Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4

British Journal of Pharmacology

Volumn 126, Issue 1, 1999, Pages 45-50

  Cunha, F Q ^a,c   Poole, S ^a   Lorenzetti, B B ^b   Veiga, F H ^a   Ferreira, S H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bradykinin; Inflammatory hyperalgesia; Interleukin 1 ; Interleukin 4; Interleukin 8; Prostaglandin E 2; Tumour necrosis factor alpha

Indexed keywords

BRADYKININ; CARRAGEENAN; CYTOKINE; CYTOKINE ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HYPERALGESIA; INFLAMMATION; MAST CELL; NONHUMAN; NUDE MOUSE; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES, MONOCLONAL; BRADYKININ; CARRAGEENAN; CELL COUNT; CYTOKINES; DEXTRANS; DINOPROSTONE; DRUG SYNERGISM; EXCIPIENTS; FOOT; HINDLIMB; HYPERALGESIA; INFLAMMATION; INTERLEUKIN-1; INTERLEUKIN-4; INTERLEUKIN-8; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MAST CELLS; MICE; RATS; RATS, NUDE; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032921150     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702266     Document Type: Article

References (36)

1. CALLARD, R.E., MATTHEUS, D.J. & HIBBERT, L. (1996). IL-4 and IL-I3 receptors: are they one and the same? Immunol. Today, 17, 108-110.
2. CASSATELLA, M.A., MEDA, L., BONORA, S., CESKA, M. & CONSTANTIN, G. (1993). InterIeukin-10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumour necrosis factor and IL-l/J in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med., 178, 2207-2211.
3. CUNHA, F.Q., POOLE, S., LORENZETTI, B.B. & FERREIRA, S.U. (1991). Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol., 104,765-767.
4. CUNHA, F.Q., POOLE, S., LORENZETTI, B.B. & FERREIRA, S.U. (1992). The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol.. 107,660-664.
5. CUNHA, F-Q., BOUKILI, M.A., BRAGA, D.A., MOTTA, J.I., VARGAFTIG, BB. & FERREIRA, S.U. (1993). Blockade by ferispiride of endotoxin-induced neutrophil migration in the rat. Eur. J. Pharmacol.,238,41-52.
6. DINARELLO, C.A., CANNON, J.G., WOLFF, S.M., BERNHEIM, H.A., BEUTLER, B., CERAMI, A., FIGARI, I.S., PALLAD1NO JR, M.A. & O'CONNOR, J.V. (1986). Tumour necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J. Exp. Med.. 163, 1443-1449.
7. DINARELLO. (1991). Interleukin-1 and interleukin-l antagonism. Blood. 77', 1627-1652.
8. DI ROSA, M., GIROUD, J.P. & WILLOUGHBY, D.A. (1971). Studies of the mediators of the acute inflammatory response in rats in different sites by carrageenin and turpentine. J. Palhol.. 104, 1529.
9. ELIAS, J.A., LENTZ, V. & CUMMINGS, P.J. (1991). Transforming growth factor-/? regulation of 1L-6 production by unstimulated and IL-l-stimulated human fibroblasts. J. Immunol., 146, 3437-3443.
10. ENDO, T., OGUSHI, F. &. SABURO, S. (1996). LPS-dependent cyclooxygenase-2 induction in human monocytes is downregulated by IL-13, but not by IFN-y. J. Immunol., 156, 2240-2246.
11. FACCIOLI, L.H., SOUZA, G.E.P., CUNHA, F.Q., POOLE, S. & FERREIRA, S.U. (1990). Recombinant interleukin-1 and tumour necrosis factor induce neutrophil migration ;/i v/ro by indirect mechanisms. Agents Actions, 30, 344-349.
12. FENTON, M.J., BURAS, J.A. & DONELLY, R.P. (1992). IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J. Immunol., 149, 1283-1288.
13. FERREIRA, S.U. & LORENZETTI, B.B. (1981). Prostaglandin hyperalgesia, IV: a metabolic process. Prostaglanilins, 21, 789792.
14. FERREIRA, S.H., LORENZETTI, B.B., BRISTOW, A.F. & POOLE, S. (1988). Interleukin-I/? as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature, 33-4, 698-699.
15. FERREIRA, S.U., LORENZETTI, B.B. & CORREA, F.M.A. (1978). Central and peripheral antialgesic action of aspirin-like drugs. Eur. J. Pliarniacol., S3, 39-48.
16. FERREIRA, S.U., LORENZETTI, B.B. &. POOLE, S. (1993). Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pliarniacol., 110, 1227-1231.
17. FIORENTINO, D.F., ZLOTNIK, A., MOSMANN, T.R., HOWARD, M. & O'GARRA, A. (1991). IL-10 inhibits cytokine production by activated macrophages. J. Immunol., 147, 3815-3822.
18. HART, P.R., VITTI, G.F., BURGESS, D.R., WHITTY, G.A, PICCOLI, D.S. & HAMILTON, J.A. (1989). Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor a, interleukin 1, and prostaalandin E->. Proc. Natl. Acail. Sei. U.S.A., 86, 3803-3807.
19. LORD, C.J.M. & LAMB, J.R. (1996). TH2 cells in allergic inflammation: a target of immunotherapy. Clin. Exp. Allergy, 26, 756-765.
20. LUMPKIN, M.D. (1987). The regulation of ACTH secretion by IL-1. Science, 238, 452-454.
21. MORSTYN, G. & BURGESS, A.W. (1988). Hemopoietic growth factors: a review. Cancer Res., 48, 5624-5637.
22. NAKAMURA, M. & FERREIRA, S.U. (1987). A peripheral sympathetic component in inflammatory hyperalgesia. Eur. J. Pliarmacol., 135, 145-153.
23. NISHIDA, S. & TOMIZAWA, S. (1980). Effects of compound 48/80 on dextran-induced paw edema and histamine content of inflammatory exudate. Bioch. Pliarniacol., 29, 1073-1075.
24. NISHIDA, S., WAGAWA, K. & TOMIZAWA, S. (1978). Correlation between histamine content in exudate and degree of edema produced by dextran. Bioch. Pliarniacol., 27, 2641-2646.
25. POOLE, S., CUNHA, F.Q., SELKIRK, S., LORENZETTI, B.B. & FERREIRA, S.H. (1995). Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pltarmacol., 115, 684-688.
26. RANKIN, E.C., CHOY, E.H., KASSIMOS, D., KINGSLEY, G.H., SOPWITH, A.M., ISENBERG, D.A. & PANAYI, G.S. (1995). The therapeutic effects of an engineered human anti-tumour necrosis factor alpha antibody (CDP571) in rheumatoid arthritis. Br. J. Rhcwnatol., 34, 334-342.
27. ROCKEN, M., RACKE, M. & SHEVACH, E.M. (1996). IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Imnnmol. Today, 17, 225-231.
28. SEIBERT, K., ZIIANG, Y., LEAHY, K., HAUSER, S., MASFERRER, J., PERKINS, V., LEE, L. & ISAKSON, P. (1994). Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc. Nail. Acad. Sei. U.S.A.,91,12013-12017.
29. SEITZ, M., LOETSCHER, P., DEWALD, B., TOWBIN, H., CESKA, M. & BAGGIOLINI, M. (1994). Production of interleukin-1 receptor antagonist, inflammatory chemotactic proteins, and prostaglandin E by rheumatoid and osteoarthritic synoviocytes-regulation by IFN-/ and 1L-4. J. Imnnmol., 152, 2060-2065.
30. STANDIFORD, T.J., STRIETER, R.M., CHENSUE, S.W., WESTWICK, J., KASAHARA, K. & KUNKEL, S.L. (1990). IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J. Imnnmol., 145, 1435-1439.
31. STEFFERL, A., HOPKINS, S.J., ROTHWELL, N.J. & LUHESHI, G.N. (1996). The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat. Br. J. Pharmacol., 118, 1919-1924.
32. TIFFANY, C.W. &. BURCH, R.M. (1989). Bradykinin stimulates tumour necrosis factor and interleukin 1 release from macrophages. FEBS Lett., 247, 189-192.
33. TUNON DE LARA, J.M., OKAYAMA, Y., MCEUEN, A.R., HEUSSER, C.H., CHURCH, M.K. & WALLS, A.F. (1994). Release and inactivation of interleukin-4 by mast cells. In: {itJCells and cytokines in lung inflammation eds. Chignard, M., Pretolani, M., Renesto, P and Vargaftig, B.B. Ann. A'. Y. Acad. Sei., 725, SO58.
34. VANNIER, E., MILLER, L.C. & DINARELLO, CA. (1992), Coordinated anti-inflammatory effects of interleukin-4: Interleukin-4 suppresses interleukin-1 production but up-regulates gene expression and synthesis of interleukin-1 receptor antagonist. Proc. Nail. Acad. Sei. U.S.A., 89, 4076-4080.
35. WATKINS, L.R., GOEHLER, L.E., RELTON, J. BREWER, M.T. & MAIER, S.F. (1995). Mechanisms of tumour necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain-Res., 692, 244-250.
36. WATKINS, L.R., WIERTELAK, E.P., GOEHLER, L.E., SMITH, K.P., MARTIN, D. & MAIER, S.F. (1994). Characterization of cytokineinduced hyperalgesia. Brain-Res., 654, 15-26.